E-LIB Suche - Ergebnisse für: Vulsteke, C.

1

39MO Phase III ENGOT-En9/LEAP-001 study: Lenvatinib + pembr..:

Pignata, S. ; Marth, C. ; Moore, R.G....
ESMO Open. 9 (2024) - p. 103539 , 2024

Link: https://doi.org/10.1016/..

2

A phase II study (AARDVARC) of AZD4635 in combination with ..:

Alonso-Gordoa, T. ; Goodman, M. ; Vulsteke, C....
ESMO Open. 9 (2024) 6 - p. 103446 , 2024

Link: https://doi.org/10.1016/..

3

247P Real-world evidence of immune checkpoint inhibitor tre..:

Geldhof, V. ; Oeste, C.L. ; Verbiest, A.T.L....
ESMO Open. 9 (2024) - p. 102709 , 2024

Link: https://doi.org/10.1016/..

4

33O PRIMA/ENGOT-OV26/GOG-3012 study: Long-term conditional ..:

Gonzalez Martin, A.J. ; Pothuri, B. ; Vergote, I.B....
ESMO Open. 8 (2023) 1 - p. 100813 , 2023

Link: https://doi.org/10.1016/..

5

114P Real-world insights on pan-cancer immune checkpoint in..:

Verbiest, A.T.L. ; Delombaerde, D.L. ; Verhaert, M....
Immuno-Oncology and Technology. 20 (2023) - p. 100586 , 2023

Link: https://doi.org/10.1016/..

6

112P Close cardiovascular monitoring during the early stage..:

Delombaerde, D.L. ; Vulsteke, C. ; Van de Veire, N....
Immuno-Oncology and Technology. 20 (2023) - p. 100584 , 2023

Link: https://doi.org/10.1016/..

7

Comparison of S1 antibody titers between BNT162b2 and ChAdO..:

van Dam, P.A. ; Debie, Y. ; Teuwen, L....
ESMO Open. 7 (2022) 2 - p. 100414 , 2022

Link: https://doi.org/10.1016/..

8

Clinical implications of isolated troponinemia following im..:

Delombaerde, D. ; Vervloet, D. ; Franssen, C....
ESMO Open. 6 (2021) 4 - p. 100216 , 2021

Link: https://doi.org/10.1016/..

9

Malnutrition prevalence in advanced cancer patients in Belg..:

Caekelbergh, K. ; Sanchez, E. ; Rasschaert, M....
Clinical Nutrition ESPEN. 46 (2021) - p. S753-S754 , 2021

Link: https://doi.org/10.1016/..

10

ENGOT-en9/LEAP-001: A phase III, randomized, active-control..:

Marth, C. ; Vulsteke, C. ; Rubio, M.J.R....
Gynecologic Oncology. 159 (2020) - p. 221 , 2020

Link: https://doi.org/10.1016/..

11

KEYNOTE-361: Phase 3 trial of pembrolizumab ± chemotherapy ..:

Powles, T. ; Loriot, Y. ; Gschwend, J.E....
European Urology Supplements. 17 (2018) 2 - p. e1147-e1148 , 2018

Link: https://doi.org/10.1016/..

12

Impact of genetic variability and treatment-related factors..:

Vulsteke, C. ; Pfeil, A. M. ; Schwenkglenks, M....
Breast Cancer Research and Treatment. 147 (2014) 3 - p. 557-570 , 2014

Link: https://doi.org/10.1007/..

13

435 Genetic Variability in the Methylenetetrahydrofolate Re..:

Vulsteke, C. ; Lambrechts, D. ; Dieudonne, A.S....
European Journal of Cancer. 48 (2012) - p. S173-S174 , 2012

Link: https://doi.org/10.1016/..

14

415 Genetic Variability in Multi Drug Resistance Protein 1 ..:

Vulsteke, C. ; Lambrechts, D. ; Dieudonné, A.S....
European Journal of Cancer. 48 (2012) - p. S167 , 2012

Link: https://doi.org/10.1016/..

15

43 Three-year follow-up of an adjuvant Phase II study looki..:

Vulsteke, C. ; Paridaens, R. ; Dirix, L....
European Journal of Cancer Supplements. 8 (2010) 3 - p. 71 , 2010

Link: https://doi.org/10.1016/..